Semaglutide and Viagra: what taking both means for you

Why men on semaglutide ask about Viagra

It is genuinely common for men starting a weight-loss medicine to already be taking sildenafil, or to be thinking about it. That is not a surprise: excess weight is one of the most well-established contributors to erectile dysfunction, raising cardiovascular risk, affecting testosterone levels and reducing vascular elasticity. The question usually comes from a sensible place — someone managing two things at once and wanting to know whether the medicines pull in opposite directions.

If that is where you are right now, the short answer is reassuring. The NHS medicines page for semaglutide does not list sildenafil among the interactions that require clinical caution, and there is no documented pharmacodynamic clash between the two. Sildenafil works by inhibiting PDE5 to relax smooth muscle in penile vasculature; semaglutide acts on GLP-1 receptors in the gut, brain and pancreas. The mechanisms are largely separate.

The more nuanced point (and the one worth pausing on) is gastric emptying. Semaglutide slows the rate at which the stomach empties, which can affect how quickly some oral medicines reach the bloodstream. For sildenafil, which is already known to have variable absorption depending on food and timing, this could theoretically shift the window in which it takes effect. The clinical significance of this is not clearly established, but it is a sensible thing to mention to a prescriber, particularly if you notice that sildenafil seems less predictable than it used to. You can read more about how semaglutide works and its broader effects on the body.

What the cardiovascular overlap actually means

Both medicines touch the heart and circulation, though in very different ways. Sildenafil lowers blood pressure, particularly in the systemic circulation, which is why it is contraindicated with nitrate medicines. Semaglutide, conversely, has a modest blood-pressure-lowering effect tied to weight loss, and the STEP 1 trial published in the New England Journal of Medicine showed meaningful reductions in cardiometabolic risk markers alongside the average 15% weight reduction at 68 weeks.

For most men, these cardiovascular effects are likely to work in the same broad direction: lower blood pressure, reduced arterial stiffness, better metabolic health. That is not the same as saying the combination is risk-free for everyone. Men with existing heart conditions, those already on antihypertensive medicines, or those whose blood pressure runs low should have an explicit conversation with a prescriber before combining them. The concern is less about the two medicines themselves and more about the cumulative blood-pressure effect in someone already on a third agent.

Our clinical team at nume reviews each patient's full health history before any treatment is approved, exactly the kind of personalised check that matters in this situation. If you are weighing up semaglutide and erectile dysfunction more broadly, there is a dedicated page that covers the evidence in more depth.

Does weight loss on semaglutide help with erectile dysfunction anyway?

Possibly, yes, and for some men, meaningfully so. Erectile dysfunction in men with obesity frequently has a vascular and hormonal basis that responds to weight loss. Fat tissue, particularly visceral fat, converts testosterone to oestrogen and contributes to endothelial dysfunction. As weight falls, testosterone levels often rise, blood flow to penile tissue improves, and the psychological confidence that tends to erode with excess weight can return.

None of this means semaglutide is a treatment for erectile dysfunction, it is not licensed for that, and the research is not there yet. But men who achieve substantial weight reduction do, in some cases, find that their need for sildenafil decreases or becomes less frequent. That is worth knowing, because it shapes the conversation with your prescriber: are you managing a long-term condition independently of weight, or is the erectile dysfunction partly downstream of the obesity itself? The answer affects how the two medicines are best managed together.

For an overview of Wegovy as a treatment and the eligibility criteria involved, the Wegovy page covers both clearly. If you are thinking about the wider costs and what private treatment includes, the Wegovy cost guide sets out what a legitimate price should cover. If you are curious about the semaglutide trade name and why the same active ingredient appears under different brand names, that page explains the distinction clearly. The NHS medicines page for semaglutide lists the full interaction and safety profile in plain language and is the right starting point for anyone who wants to check both medicines against each other.

The practical decision: one prescriber who knows both

The safest path is straightforward. Whoever prescribes your semaglutide should know you take sildenafil, and whoever prescribes your sildenafil should know you are on semaglutide. That sounds obvious, but it is where things sometimes fall short when medicines are obtained from separate sources without joined-up clinical oversight.

At nume, every consultation is read personally by a GPhC-registered Independent Prescriber on the same day you submit it. There are no automated approvals, a real clinician reads your answers, checks your health history, and makes a clinical judgment. If you are already on sildenafil, saying so in your consultation means that context is part of the review. That is the standard you should expect from any regulated online pharmacy, and you can verify any UK pharmacy's registration through the GPhC register.

If you are ready to explore whether semaglutide 1 mg or another dose is appropriate for you, check your eligibility with a free consultation. There is no obligation, and your answers are reviewed the same day.